Telomir Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Feb 24 | BuyUS$343,000 | Brian McNulty | Individual | 49,000 | US$7.00 | |
13 Feb 24 | BuyUS$623,000 | Bayshore Trust | Company | 89,000 | US$7.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 2,050,176 | 6.92% |
Individual Insiders | 5,323,748 | 18% |
Private Companies | 6,821,076 | 23% |
General Public | 15,414,814 | 52.1% |
Dilution of Shares: TELO only recently listed within the past 12 months
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,821,076 | US$30.5m | 0% | no data | |||
2,119,220 | US$9.5m | 0% | no data | |||
1,927,050 | US$8.6m | 0% | no data | |||
1,151,527 | US$5.1m | 3,920% | no data | |||
487,805 | US$2.2m | 0% | no data | |||
487,805 | US$2.2m | 0% | no data | |||
366,878 | US$1.6m | 317% | no data | |||
238,737 | US$1.1m | 260% | no data | |||
101,134 | US$452.1k | 0% | no data | |||
51,364 | US$229.6k | 2.39% | no data | |||
51,194 | US$228.8k | 110% | 0.02% | |||
48,781 | US$218.1k | 0% | no data | |||
48,781 | US$218.1k | 0% | no data | |||
48,781 | US$218.1k | 0% | no data | |||
48,680 | US$217.6k | 0% | no data | |||
36,094 | US$161.3k | 99.1% | no data | |||
30,000 | US$134.1k | 0% | no data | |||
24,391 | US$109.0k | 0% | no data | |||
14,623 | US$65.4k | 0% | 0.01% | |||
11,796 | US$52.7k | -49.6% | no data | |||
11,206 | US$50.1k | 126% | no data | |||
10,850 | US$48.5k | 0% | no data | |||
10,000 | US$44.7k | 0% | no data | |||
7,018 | US$31.4k | 325% | no data | |||
4,176 | US$18.7k | -17.5% | no data |